Eupraxia is a clinical-stage biotechnology company focused on developing locally delivered, extended-release products that have the potential to address therapeutic areas with high unmet medical need. DiffuSphere, a proprietary, polymer-based micro-sphere technology, is designed to facilitate targeted drug delivery of both existing and novel drugs. The technology is designed to support an extended duration of effect and delivery of drugs in a hyper-localized fashion, targeting only the tissues that physicians want to treat. We believe the potential for fewer adverse events may be achieved through the precision targeting and the stable and flat delivery of the active ingredient when using the DiffuSphere technology, versus the peaks and troughs seen with more traditional drug delivery methods. The precision of Eupraxia's DiffuSphere technology platform has the potential to augment and transform existing FDA-approved drugs to improve their safety, tolerability, efficacy and duration of effect. The potential uses in therapeutic areas may go beyond pain and inflammatory gastrointestinal disease, where Eupraxia currently is developing advanced treatments, also to be applicable in oncology, infectious disease and other critical disease areas.
Eupraxia's EP-104GI is currently in a Phase 1b/2 trial, the RESOLVE trial, for the treatment of EoE. EP-104GI is administered as an injection into the esophageal wall, providing local delivery of drug. This is a unique treatment approach for EoE. Eupraxia also recently completed a Phase 2b clinical trial (SPRINGBOARD) of EP-104IAR for the treatment of pain due to knee osteoarthritis. The trial met its primary endpoint and three of the four secondary endpoints. In addition, Eupraxia is developing a pipeline of later and earlier-stage long-acting formulations. Potential pipeline indications include candidates for other inflammatory joint indications and oncology, each designed to improve on the activity and tolerability of currently approved drugs. For further details about Eupraxia, please visit the Company's website at:
As our Clinical Research Associate (CRA) you will be primarily responsible for the operational management and oversight of Eupraxia clinical study’s monitoring.
Travel requirement: Must be willing to travel domestically and internationally (approximately 20-25%), as needed
Reports to: SVP of Clinical Operations
Salary Range: $115,000 - $145,000 annually depending on education and relevant experience.
...Front EndDeveloper Overview A growing technology organization is seeking a Front End Developer to join its on-site engineering team. This role focuses on building and maintaining scalable web applications with a strong emphasis on front-end development. The...
...: Posting Information Posting Information Position Title Administrative Assistant III and AVISO Coordinator Job Duties Butler Community College is seeking an Administrative Assistant to be responsible for the management of the academic office which serves the...
Transportation Adecco , Class C Non-CDL , Class CWest Chester, PENNSYLVANIA , Pay: $16 - $18Drivers must have clean driving record no more than... ...License or CDL B license for 2 years or moreA current DOT MEDICAL CARD2 years of Local Delivery experienceMust have a...
...Director for Growth supporting the Civil Space Operating Unit within the Space Systems and Solutions Sector with a primary focus on NASAs Glenn Research Center. This professional will support building the pipeline for organic growth through business development activities...
...About Rivian Rivianis on a mission to keep the world adventurous forever. This goes for the emissions-free Electric Adventure Vehicles we build, and the curious, courageous souls we seek to attract. As a company, we constantly challenge whats possible, never...